Type 1 Diabetes Clinical Trial
Official title:
Sleep and Psychosocial Outcomes After Initiation of Advanced Hybrid Closed-Loop Insulin Delivery Systems in Youth With Type 1 Diabetes and Their Parents
Verified date | April 2022 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.
Status | Completed |
Enrollment | 46 |
Est. completion date | April 1, 2022 |
Est. primary completion date | April 1, 2022 |
Accepts healthy volunteers | |
Gender | All |
Age group | 2 Years to 17 Years |
Eligibility | Inclusion Criteria: - Child diagnosed with type 1 diabetes for at least 3 months - Child receives clinical care at the Barbara Davis Center for Diabetes - Child starting an advanced HCL system as part of routine diabetes care - Child currently living with a parent who is willing to complete surveys for this study - Family able to read and speak English - Parent lives at home with the child with type 1 diabetes - Parent able to read and speak English Exclusion Criteria: - Child has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea - Child participating in an interventional research protocol - Child unable to complete study procedures - Parent has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea - Parent unable to complete study procedures |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado, Barbara Davis Center | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration of Sleep | Change in duration of sleep before and after starting the advanced hybrid closed-loop system using surveys and activity watches | End of study (6 months) | |
Secondary | Impact on Diabetes Distress | Change in diabetes-related distress using the validated Problem Areas in Diabetes survey | End of study (6 months) | |
Secondary | Impact on Quality of Life | Change in quality of life using the validated survey Pediatric Quality of Life Inventory Diabetes Module (PedsQL) | End of study (6 months) | |
Secondary | Impact on Fear of Hypoglycemia | Change in fear of hypoglycemia using the validated hypoglycemia fear survey | End of study (6 months) | |
Secondary | Impact on Perceptions of Diabetes Technology | Change in diabetes technology perceptions using the validated survey Diabetes Technology Questionnaire | End of study (6 months) | |
Secondary | Impact on Hybrid Closed-Loop System Use Perceptions | Change in perceptions of hybrid-closed loop systems using the validated INSPIRE survey | End of study (6 months) | |
Secondary | Impact of Sleep on Glycemic Variability | Correlation of sleep duration and glycemic variability using hybrid closed loop device download to analyze time in range, time with low glucose and time with high glucose | End of study (6 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02855307 -
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
|
Phase 2 |